Viking Therapeutics, Inc. (VKTX) › Net IncomeViking Therapeutics, Inc. (VKTX) — Net IncomeAnnual figures by fiscal year, from SEC filings.2014: -$21.88M2015: -$23.40M2016: -$14.73M2017: -$20.58M2018: -$22.06M2019: -$25.78M2020: -$39.49M2021: -$54.99M2022: -$68.87M2023: -$85.89M2024: -$109.96M2025: -$359.64M-$359.64M2014Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$359.64M-227.1%2024-$109.96M-28.0%2023-$85.89M-24.7%2022-$68.87M-25.2%2021-$54.99M-39.2%2020-$39.49M-53.2%2019-$25.78M-16.8%2018-$22.06M-7.2%2017-$20.58M-39.7%2016-$14.73M+37.1%2015-$23.40M-6.9%2014-$21.88M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share